AVITA Medical (RCEL) Profit After Tax (QoQ) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | AVITA Medical | 121.89 Mn | 103.71 Mn | 14.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.88% |
| Sep 30, 2025 | -32.93% |
| Jun 30, 2025 | 28.42% |
| Mar 31, 2025 | -19.59% |
| Dec 31, 2024 | 28.49% |
| Sep 30, 2024 | -5.28% |
| Jun 30, 2024 | 17.50% |
| Mar 31, 2024 | -164.09% |
| Dec 31, 2023 | 18.90% |
| Sep 30, 2023 | 16.10% |
| Jun 30, 2023 | -12.62% |
| Mar 31, 2023 | -72.24% |
| Dec 31, 2022 | 4.21% |
| Sep 30, 2021 | -26.07% |
| Jun 30, 2021 | 21.33% |
| Mar 31, 2021 | -6.31% |
| Dec 31, 2020 | 44.84% |
| Sep 30, 2020 | 20.81% |
| Jun 30, 2020 | 14.18% |
| Mar 31, 2020 | -43.29% |
| Dec 31, 2019 | -194.50% |
| Sep 30, 2019 | 53.20% |
| Jun 30, 2019 | -23.26% |
| Mar 31, 2019 | 1.34% |
| Dec 31, 2018 | -24.47% |
| Sep 30, 2018 | 59.75% |